On October 25, 2018 RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company primarily focused on proprietary drugs for gastrointestinal diseases, reported that Mr. Adi Frish, Senior VP Business Development and Licensing, will present a corporate overview at the BIO-Europe 2018 Conference, on Tuesday, November 6, 2018, at 4:15 p.m. CET, at the Bella Center in Copenhagen, Denmark (Press release, RedHill Biopharma, OCT 25, 2018, View Source [SID1234530282]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A copy of the presentation to be delivered by Mr. Frish will be available on the Company’s website and may be viewed at: View Source